FR2512670B1 - Capsules contenant le principe actif d'un allergene et procede pour leur preparation - Google Patents

Capsules contenant le principe actif d'un allergene et procede pour leur preparation

Info

Publication number
FR2512670B1
FR2512670B1 FR8208989A FR8208989A FR2512670B1 FR 2512670 B1 FR2512670 B1 FR 2512670B1 FR 8208989 A FR8208989 A FR 8208989A FR 8208989 A FR8208989 A FR 8208989A FR 2512670 B1 FR2512670 B1 FR 2512670B1
Authority
FR
France
Prior art keywords
capsules containing
allergen
preparation
active ingredient
choconstritive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8208989A
Other languages
English (en)
French (fr)
Other versions
FR2512670A1 (fr
Inventor
Gaetano Melillo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorio Farmaceutico Lofarma Sas
Original Assignee
Laboratorio Farmaceutico Lofarma Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorio Farmaceutico Lofarma Sas filed Critical Laboratorio Farmaceutico Lofarma Sas
Publication of FR2512670A1 publication Critical patent/FR2512670A1/fr
Application granted granted Critical
Publication of FR2512670B1 publication Critical patent/FR2512670B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR8208989A 1981-06-04 1982-05-19 Capsules contenant le principe actif d'un allergene et procede pour leur preparation Expired FR2512670B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT22136/81A IT1220979B (it) 1981-06-04 1981-06-04 Capsule contenenti un allergene e procedimento per la loro preparazione

Publications (2)

Publication Number Publication Date
FR2512670A1 FR2512670A1 (fr) 1983-03-18
FR2512670B1 true FR2512670B1 (fr) 1986-12-19

Family

ID=11192020

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8208989A Expired FR2512670B1 (fr) 1981-06-04 1982-05-19 Capsules contenant le principe actif d'un allergene et procede pour leur preparation

Country Status (13)

Country Link
US (1) US4681752A (cg-RX-API-DMAC10.html)
EP (1) EP0067130B1 (cg-RX-API-DMAC10.html)
JP (1) JPS57212114A (cg-RX-API-DMAC10.html)
AT (1) ATE20518T1 (cg-RX-API-DMAC10.html)
CA (1) CA1207663A (cg-RX-API-DMAC10.html)
CH (1) CH650925A5 (cg-RX-API-DMAC10.html)
DE (1) DE3271829D1 (cg-RX-API-DMAC10.html)
DK (1) DK153920C (cg-RX-API-DMAC10.html)
FR (1) FR2512670B1 (cg-RX-API-DMAC10.html)
GR (1) GR76810B (cg-RX-API-DMAC10.html)
IL (1) IL65875A (cg-RX-API-DMAC10.html)
IT (1) IT1220979B (cg-RX-API-DMAC10.html)
NO (1) NO156275C (cg-RX-API-DMAC10.html)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811128A (en) * 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US5075109A (en) * 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
ATE77947T1 (de) * 1987-04-09 1992-07-15 Fisons Plc Pentamidin enthaltende pharmazeutische zusammensetzungen.
US5021554A (en) * 1989-02-24 1991-06-04 Eli Lilly And Company Process for protein particle size reduction using a fluid-energy mill
WO1992016554A1 (en) * 1991-03-14 1992-10-01 The University Of Melbourne Protein allergens of the species cynodon dactylon
CA2097932A1 (en) * 1991-10-11 1993-04-12 Shojiro Yamazaki Antibody containing composition
US5641510A (en) * 1994-07-01 1997-06-24 Genentech, Inc. Method for treating capsules used for drug storage
EP0711804A3 (de) 1994-11-14 1999-09-22 Ciba SC Holding AG Kryptolichtschutzmittel
JP2000510109A (ja) * 1996-04-29 2000-08-08 デュラ・ファーマシューティカルズ・インコーポレイテッド 乾燥粉末の吸入方法
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
PT1494732E (pt) 2002-03-20 2008-03-20 Mannkind Corp Aparelho de inalação
RU2216353C1 (ru) * 2002-10-16 2003-11-20 Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН Способ получения гранулированной лекарственной формы из аллергена клещей рода dermatophagoides farinae
MX2007001903A (es) 2004-08-20 2007-08-02 Mannkind Corp Catalisis de sintesis de dicetopiperazina.
KR20130066695A (ko) 2004-08-23 2013-06-20 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는 디케토디옥산염
KR101486397B1 (ko) 2005-09-14 2015-01-28 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
BRPI0707991B8 (pt) 2006-02-22 2021-05-25 Mannkind Corp métodos de preparação de um medicamento em pó seco com uma propriedade farmacêutica melhorada, dito pó seco e uso de uma quantidade efetiva do pó seco
RU2608439C2 (ru) 2008-06-13 2017-01-18 Маннкайнд Корпорейшн Ингалятор для сухого порошка и система для доставки лекарственных средств
US8485180B2 (en) * 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
EP2609954B1 (en) 2008-06-20 2021-12-29 MannKind Corporation An interactive apparatus for real-time profiling of inhalation efforts
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2676695A3 (en) 2009-03-11 2017-03-01 MannKind Corporation Apparatus, system and method for measuring resistance of an inhaler
CN102647979B (zh) 2009-06-12 2015-03-04 曼金德公司 具有确定比表面积的二酮哌嗪颗粒
EP2496295A1 (en) 2009-11-03 2012-09-12 MannKind Corporation An apparatus and method for simulating inhalation efforts
EP2694402B1 (en) 2011-04-01 2017-03-22 MannKind Corporation Blister package for pharmaceutical cartridges
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
WO2013063160A1 (en) 2011-10-24 2013-05-02 Mannkind Corporation Methods and compositions for treating pain
CA2878457C (en) 2012-07-12 2021-01-19 Mannkind Corporation Dry powder drug delivery systems and methods
WO2014066856A1 (en) 2012-10-26 2014-05-01 Mannkind Corporation Inhalable influenza vaccine compositions and methods
EP3587404B1 (en) 2013-03-15 2022-07-13 MannKind Corporation Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
CA2918369C (en) 2013-07-18 2021-06-29 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
EP3030294B1 (en) 2013-08-05 2020-10-07 MannKind Corporation Insufflation apparatus
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3148121A (en) * 1960-01-27 1964-09-08 Miles Lab Water-insoluble whole inhalant complex and method of making same
GB1055465A (en) * 1962-09-27 1967-01-18 Vantorex Ltd Allergenic aerosol compositions
GB1182779A (en) * 1966-09-17 1970-03-04 Fisons Pharmaceuticals Ltd Inhalation Device
GB1247614A (en) * 1969-06-20 1971-09-29 Miles Lab Improved therapeutic and diagnostic allergenic extract and process for preparing same
BR6915418D0 (pt) * 1969-10-13 1973-03-13 Synergistics Inc Processo de preparacao de um composto antigeno de acaros e de seu soro e sua titulacao
GB1381872A (en) * 1971-06-22 1975-01-29 Fisons Ltd Pharmaceutical compositions for inhalation
NL7316346A (cg-RX-API-DMAC10.html) * 1972-12-11 1974-06-13
US3995023A (en) * 1972-12-11 1976-11-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Process for the production of allergen-containing extracts
FR2466991A1 (fr) * 1979-10-08 1981-04-17 Pasteur Institut Perfectionnement a la preparation d'allergene

Also Published As

Publication number Publication date
EP0067130A2 (en) 1982-12-15
US4681752A (en) 1987-07-21
IL65875A0 (en) 1982-08-31
IT1220979B (it) 1990-06-21
ATE20518T1 (de) 1986-07-15
GR76810B (cg-RX-API-DMAC10.html) 1984-09-04
DE3271829D1 (en) 1986-07-31
EP0067130B1 (en) 1986-06-25
EP0067130A3 (en) 1984-01-11
DK153920B (da) 1988-09-26
NO156275B (no) 1987-05-18
JPS57212114A (en) 1982-12-27
CH650925A5 (it) 1985-08-30
JPH0575726B2 (cg-RX-API-DMAC10.html) 1993-10-21
IL65875A (en) 1986-09-30
IT8122136A0 (it) 1981-06-04
CA1207663A (en) 1986-07-15
NO821832L (no) 1982-12-06
NO156275C (no) 1987-08-26
FR2512670A1 (fr) 1983-03-18
DK153920C (da) 1989-02-06
DK239782A (da) 1982-12-05

Similar Documents

Publication Publication Date Title
FR2512670B1 (fr) Capsules contenant le principe actif d'un allergene et procede pour leur preparation
ES2117642T3 (es) Preparado farmaceutico que contiene n-glicofuroles y n-etilen glicoles.
ATE157257T1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
ATE204178T1 (de) Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin
BE838924A (fr) Nouveaux esters alkyliques d'acides 1,4-dihydropyridine-carboxyliques, leur procede de preparation et medicament les contenant
ES2137948T3 (es) Sistema avanzado de administracion de medicamentos y metodo de tratamiento de trastornos psiquiatricos, neurologicos y otros con carbamacepina.
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
EP0315591A3 (en) Physiologically active substances, a process for the preparation thereof and pharmaceutical compositions containing them
DE58901002D1 (de) Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken.
ES478967A1 (es) Un procedimiento para preparar compuestos de acido 3-cefem-4-carboxilico disustituido en las posiciones 3 y 7.
Gutsell Sulfa drugs and the treatment of furunculosis in trout
FR2439194A1 (fr) Derives de la dibenzothiepine, leur procede de preparation et leur application therapeutique
BE858356A (fr) Derives d'acide 7-acylamino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique, leur procede de preparation et leur application en therapeutique
FR2346005A1 (fr) Nouvelles lactones d'acides libres du type prostaglandine, leur procede de preparation et medicament les contenant
BE878836A (fr) Derives d'acide hydroxamique, leur procede de preparation et medicament les contenant
DE59107111D1 (de) 3,5-Diiod-L-Thyronin zur TSH-Suppression und Behandlung von Struma
SU315388A1 (ru) Лекарственное средство
Leek et al. Effect of monensin on experimental infections of Eimeria ninakohlyakimovae in lambs
FR2427822A1 (fr) Medicament pour le traitement des maladies circulatoires, a base de 5-methyl-7-dimethylamino-s-triazolo (1,5-a) pyrimidine
FR2321282A1 (fr) Arylamides d'acides o-aminoalkanoique, leur procede de preparation et leur application en therapeutique
FR2344545A1 (fr) Amides d'acides (2-pyrimidinylthio)-alcanoiques ayant une activite antilipemique, procedes pour leur preparation et compositions pharmaceutiques les contenant
BE881625A (fr) Esters o-alcoxycarbonyl-phenyliques d'un acide anthranilique leur preparation et compositions pharmaceutiques en contenant
BE863851A (fr) 2,4-dichlorophenyl-imidazolyl-ethanones ou -ethanols, leur procede de preparation et medicament les contenant
SU1326744A1 (ru) Способ активации фагоцитоза макрофагов IN VIтRо
FR2496658B1 (fr) Derives de l'acide nicotinique, leur preparation et medicament contenant ces substances

Legal Events

Date Code Title Description
CJ Change in legal form
CD Change of name or company name